Articles by Daniel Marsh
U.S. Art Auction Sales Surge 23% in 2025, Led by Established Artists
U.S. art auction sales at top houses rose 23% to $3.17 billion in 2025, the first annual gain since 2022, according to Bank of America. The rebound was fueled by historical artists and a focus on quality.
FTSE 100 Recovers from Sharp Drop as Oil Price Spike Roils London
London's FTSE 100 pared steep early losses to close 0.3% lower on Monday, while the FTSE 250 fell 1.6%. A dramatic spike in oil prices above $119 a barrel, driven by Middle East conflict, triggered a broad market sell-off and renewed stagflation fears.
Lumentum Surges on S&P 500 Inclusion, Fueled by Nvidia AI Partnership
Lumentum Holdings shares rallied over 10% on news of its upcoming inclusion in the S&P 500 index, extending gains driven by a major strategic partnership with Nvidia focused on AI photonics.
Stocks Sink as Oil Surge and Jobs Data Fuel Stagflation Worries
U.S. stocks dropped sharply Monday as oil prices neared $120 per barrel and a surprise loss of 92,000 jobs in February intensified concerns about stagflation. The Dow, S&P 500, and Nasdaq each fell roughly 1.3%.
Jefferies Faces Legal Battle, Limits MFS Losses Under $20M
Jefferies Financial Group disclosed that losses from the collapse of UK lender Market Financial Solutions will likely remain below $20 million. The firm also contested a $126.4 million claim from Western Alliance Bancorporation, sparking a legal dispute.
Wealth Managers Boost QQQ Stakes, but Data Lags Market Moves
Recent SEC filings reveal two wealth managers raised their stakes in the Invesco QQQ ETF in Q3 2025, though subsequent data shows one trimmed its position by year-end. The Nasdaq-100 tracker traded near $593, down 1.1%, as investors weigh growth prospects against macro risks.
Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal
French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.
Markets Brace for Inflation Data as Oil Surge Dents Rate Cut Hopes
U.S. equity futures declined sharply Monday amid surging oil prices and weak jobs data, pushing back expectations for Federal Reserve rate cuts. Investors await critical inflation reports due this week.
TSX Set for Lower Open as Oil Spike Sparks Inflation, Recession Fears
Canada's main stock index is poised for a lower open Monday, with futures down 0.92%, after a surge in oil prices to multi-year highs intensified inflation and recession concerns, pressuring financial and mining sectors.
Hims & Hers Shares Jump on Novo Nordisk Partnership Revival
Hims & Hers Health shares surged in premarket trading Monday following reports that Novo Nordisk will resume selling its weight-loss drugs through the telehealth platform. The move marks a reversal from a patent dispute last month.